Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
10/01/2025 | Shorea LBG | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Shorea LBG | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Life Sciences Group Ltd | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Life Sciences Group Ltd | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Liu Dianbo | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Ginkgo (PTC) Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Ginkgo (PTC) Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Liu Dianbo | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
03/01/2025 | UBS Group AG | 1305(L) | 68,623,827(L) | 456,292,400(L) 360,935,000(S) | 12.13 9.60 | |
02/01/2025 | UBS Group AG | 1104(L) 1502(S) | +9,105,000(L) -82,994,302(S) | 460,222,164(L) 365,536,264(S) | 12.23 9.72 | |
26/12/2024 | UBS Group AG | 1205(L) | -499,083(L) | 451,269,014(L) 449,603,523(S) | 11.99 11.95 | |
25/12/2024 | UBS Group AG | 1104(L) | +877,500(L) | 451,690,097(L) 450,006,098(S) | 12.01 11.96 | |
24/12/2024 | UBS Group AG | 1205(L) 1502(S) | -9,398,369(L) -9,398,369(S) | 444,198,366(L) 442,514,367(S) | 11.81 11.76 | |
20/12/2024 | UBS Group AG | 1402(S) | +2,693,500(S) | 456,601,225(L) 453,596,218(S) | 12.14 12.06 | |
19/12/2024 | UBS Group AG | 1306(L) | 165,000,000(L) | 452,764,210(L) 447,053,714(S) | 12.04 11.88 | |
18/12/2024 | Liu Dianbo | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | UBS Group AG | 1502(S) | -3,089,369(S) | 460,943,069(L) 448,320,669(S) | 12.25 11.92 | |
18/12/2024 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
13/12/2024 | Kale Asset Holding Ltd | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
13/12/2024 | RRJ Capital Master Fund IV, L.P. | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
13/12/2024 | RRJ Capital IV Ltd | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
13/12/2024 | Ong Tiong Sin | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
12/12/2024 | UBS Group AG | 1402(S) | +3,166,000(S) | 463,296,075(L) 454,292,599(S) | 12.32 12.08 | |
11/12/2024 | UBS Group AG | 1502(S) | -6,942,871(S) | 451,484,577(L) 444,486,613(S) | 12.00 11.82 | |
10/12/2024 | UBS Group AG | 1402(S) | +2,390,000(S) | 461,242,758(L) 453,276,294(S) | 12.26 12.05 | |
05/12/2024 | UBS Group AG | 1113(L) | +4,243,310(L) | 455,641,276(L) 448,552,424(S) | 12.11 11.92 | |
1 2 3 4 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 13/01/2025 18:00 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |